UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Differences in Follicle-Stimulating Hormone Secretion between 45,X Monosomy Turner Syndrome and 45,X/46,XX Mosaicism Are Evident at an Early Age

The journal of clinical endocrinology and metabolism, 2006-12, Vol.91 (12), p.4896-4902

2006

Volltextzugriff (PDF)

Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care

Critical care (London, England), 2004-10, Vol.8 (5), p.R291-R298, Article R291

2004

Volltextzugriff (PDF)

CURB-65, PSI, and APACHE II to Assess Mortality Risk in Patients With Severe Sepsis and Community Acquired Pneumonia in PROWESS

Journal of intensive care medicine, 2011-01, Vol.26 (1), p.34-40

2011

Volltextzugriff (PDF)

Benefit/risk profile of drotrecogin alfa (activated) in surgical patients with severe sepsis

The American journal of surgery, 2004-09, Vol.188 (3), p.212-220

2004

Volltextzugriff (PDF)

A retrospective observational study of drotrecogin alfa (activated) in adults with severe sepsis: Comparison with a controlled clinical trial

Critical care medicine, 2008-01, Vol.36 (1), p.14-23

2008

Volltextzugriff (PDF)

Growth Hormone Replacement Therapy in Adults with Growth Hormone Deficiency Improves Maximal Oxygen Consumption Independently of Dosing Regimen or Physical Activity

The journal of clinical endocrinology and metabolism, 2008-01, Vol.93 (1), p.125-130

2008

Volltextzugriff (PDF)

Application of a population-based severity scoring system to individual patients results in frequent misclassification

Critical care (London, England), 2005-10, Vol.9 (5), p.R522-R529, Article R522

2005

Volltextzugriff (PDF)

From bench to bedside: a review of the clinical trial development plan of drotrecogin alfa (activated)

Current medical research and opinion, 2006-12, Vol.22 (12), p.2525-2540

2006

Volltextzugriff (PDF)

Steroid use in PROWESS severe sepsis patients treated with drotrecogin alfa (activated)

Critical care (London, England), 2005-10, Vol.9 (5), p.R502-R507, Article R502

2005

Volltextzugriff (PDF)

Simplified Pharmacoeconomics of Critical Care and Severe Sepsis

Journal of intensive care medicine, 2007-09, Vol.22 (5), p.283-293

2007

Volltextzugriff (PDF)

Obesity does not alter the pharmacokinetics of drotrecogin alfa (activated) in severe sepsis

The Annals of pharmacotherapy, 2005-02, Vol.39 (2), p.262-267

2005

Volltextzugriff (PDF)

Static and Dynamic Assessment of Biomarkers in Surgical Patients with Severe Sepsis

Surgical infections, 2004-09, Vol.5 (3), p.261-268

2004

Volltextzugriff (PDF)

CURB-65 SCORE AS A MEASURE OF DISEASE SEVERITY IN SEVERE SEPSIS: 203-T

Critical care medicine, 2005-12, Vol.33, p.A161

2005

Volltextzugriff (PDF)

CURB-65 PNEUMONIA SEVERITY INDEX AND APACHE II SCORES TO ASSESS MORTALITY RISK IN COMMUNITY-ACQUIRED PNEUMONIA PATIENTS FROM PROWESS

Chest, 2007-10, Vol.132 (4), p.559A-559A

2007

Volltextzugriff (PDF)

THE APPLICATION OF A POPULATION-BASED SEVERITY SCORING SYSTEM TO INDIVIDUAL PATIENTS RESULTS IN SERIOUS MISCLASSIFICATION: 46

Critical care medicine, 2004-12, Vol.32 (Supplement), p.A12

2004

Volltextzugriff (PDF)

The Pharmacokinetics of Drotrecogin Alfa (Activated) In Severe Sepsis Patients Weighing >135 kg

Chest, 2004-10, Vol.126 (4), p.863S-863S

2004

Volltextzugriff (PDF)

CURB-65, pneumonia severity index and apache ii 25 scores to assess mortality risk in community-acquired pneumonia

The Southern African journal of critical care, 2007-08, Vol.23 (1), p.45

2007

Volltextzugriff (PDF)

THE APPLICATION OF A POPULATION-BASED SEVERITY SCORING SYSTEM TO INDIVIDUAL PATIENTS RESULTS IN SERIOUS MISCLASSIFICATION: 46

Critical care medicine, 2004-12, Vol.32 (12 Suppl), p.A12-A12

2004

Volltextzugriff (PDF)

1 – 18 von 18

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(18)

Sprache

Englisch
(18)

Erscheinungsjahr

n.n

Thema

Humans
(12)
Life Sciences & Biomedicine
(9)
Science & Technology
(9)
Middle Aged
(7)
Recombinant Proteins - Therapeutic Use
(7)
Female
(6)
Protein C - Therapeutic Use
(6)
Severe Sepsis
(6)
Adult
(5)
Biological And Medical Sciences
(5)
Critical Care Medicine
(5)
Drotrecogin Alfa
(5)
General & Internal Medicine
(5)
Male
(5)
Medical Sciences
(5)
Sepsis - Drug Therapy
(5)
Anti-Infective Agents - Therapeutic Use
(4)
Apache
(4)
Aged
(3)
Analysis Of Variance
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Differences in Follicle-Stimulating Hormone Secretion between 45,X Monosomy Turner Syndrome and 45,X/46,XX Mosaicism Are Evident at an Early Age

Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care

CURB-65, PSI, and APACHE II to Assess Mortality Risk in Patients With Severe Sepsis and Community Acquired Pneumonia in PROWESS

Benefit/risk profile of drotrecogin alfa (activated) in surgical patients with severe sepsis

A retrospective observational study of drotrecogin alfa (activated) in adults with severe sepsis: Comparison with a controlled clinical trial

Growth Hormone Replacement Therapy in Adults with Growth Hormone Deficiency Improves Maximal Oxygen Consumption Independently of Dosing Regimen or Physical Activity

Application of a population-based severity scoring system to individual patients results in frequent misclassification

From bench to bedside: a review of the clinical trial development plan of drotrecogin alfa (activated)

Steroid use in PROWESS severe sepsis patients treated with drotrecogin alfa (activated)

Simplified Pharmacoeconomics of Critical Care and Severe Sepsis

Obesity does not alter the pharmacokinetics of drotrecogin alfa (activated) in severe sepsis

Static and Dynamic Assessment of Biomarkers in Surgical Patients with Severe Sepsis

CURB-65 SCORE AS A MEASURE OF DISEASE SEVERITY IN SEVERE SEPSIS: 203-T

CURB-65 PNEUMONIA SEVERITY INDEX AND APACHE II SCORES TO ASSESS MORTALITY RISK IN COMMUNITY-ACQUIRED PNEUMONIA PATIENTS FROM PROWESS

THE APPLICATION OF A POPULATION-BASED SEVERITY SCORING SYSTEM TO INDIVIDUAL PATIENTS RESULTS IN SERIOUS MISCLASSIFICATION: 46

The Pharmacokinetics of Drotrecogin Alfa (Activated) In Severe Sepsis Patients Weighing >135 kg

CURB-65, pneumonia severity index and apache ii 25 scores to assess mortality risk in community-acquired pneumonia

THE APPLICATION OF A POPULATION-BASED SEVERITY SCORING SYSTEM TO INDIVIDUAL PATIENTS RESULTS IN SERIOUS MISCLASSIFICATION: 46

Suchergebnisse filtern